Literature DB >> 10383373

In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

L Steele-Moore, K Stark, W J Holloway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10383373      PMCID： PMC89317     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-06-27

3.  Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study.

Authors:  H Bacellar; A Muñoz; D R Hoover; J P Phair; D R Besley; L A Kingsley; S H Vermund
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

4.  Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.

Authors:  T T Ward; D Rimland; C Kauffman; M Huycke; T G Evans; L Heifets
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

5.  Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.

Authors:  C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 6.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 7.  Mycobacterium avium complex infection and AIDS: advances in theory and practice.

Authors:  C A Benson; J J Ellner
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

8.  Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.

Authors:  R E Chaisson; C A Benson; M P Dube; L B Heifets; J A Korvick; S Elkin; T Smith; J C Craft; F R Sattler
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

9.  Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium.

Authors:  L B Heifets; P J Lindholm-Levy; R D Comstock
Journal:  Am Rev Respir Dis       Date:  1992-04

10.  Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.

Authors:  J A Havlik; C R Horsburgh; B Metchock; P P Williams; S A Fann; S E Thompson
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.